SCHEMBL22070643

SCHEMBL22070643

CCOC(=O)C1=Cc2ccc(C=O)cc2OC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.44
ALDH1A1 P00352 9/20 0.42
KDM4E B2RXH2 6/20 0.42
KMT2A Q03164 1/20 0.41
PKM P14618 1/20 0.40
NR1H4 Q96RI1 1/20 0.39
HTT P42858 1/20 0.38
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
TDP1 Q9NUW8 2/20 0.37
HSD17B10 Q99714 1/20 0.37
LMNA P02545 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MAPT P10636 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
POLB P06746 1/20 0.36
MAPK1 P28482 1/20 0.36
HPGD P15428 2/20 0.36
MAOB P27338 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13394278 0.83 ALOX5 (0.47) ALOX5ALDH1A1KDM4EKMT2APKM
SCHEMBL1503897 0.82 CA12 (0.49) ALOX5ALDH1A1KDM4EKMT2APKM
SCHEMBL22071065 0.82 ALOX5 (0.46) ALOX5ALDH1A1KDM4EKMT2APKM
SCHEMBL29435098 0.79 ALDH1A1 (0.61) ALOX5ALDH1A1KDM4EKMT2APKM
SCHEMBL4537381 0.79 ALDH1A1 (0.61) ALOX5ALDH1A1KDM4EKMT2APKM
SCHEMBL10650749 0.75 ALDH1A1 (0.50) ALOX5ALDH1A1KDM4EKMT2APKM
SCHEMBL10638674 0.75 ALOX5 (0.61) ALOX5ALDH1A1KMT2ANR1H4LMNA
SCHEMBL10471974 0.74 ALOX5 (0.54) ALOX5ALDH1A1KMT2ANR1H4HTT
SCHEMBL10471972 0.74 ALOX5 (0.54) ALOX5ALDH1A1KMT2ANR1H4HTT
SCHEMBL22771262 0.72 TLR8 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11365192-B2 Pyridine compound substituted with azole TAISHO PHARMACEUTICAL CO., LTD. (JP) 2022-06-21 US disclosed
US-20210122741-A1 PYRIDINE COMPOUND SUBSTITUTED WITH AZOLE TAISHO PHARMACEUTICAL CO., LTD (JP) 2021-04-29 US disclosed
WO-2020162612-A1 PYRIDINE COMPOUND SUBSTITUTED BY HETEROARYL 大正製薬株式会社 2020-08-13 WO disclosed
EP-3666766-A1 PYRIDINE COMPOUND SUBSTITUTED WITH AZOLE Taisho Pharmaceutical Co., Ltd. (JP) 2020-06-17 EP disclosed
CN-110914254-A Azole-substituted pyridine compound 大正制药株式会社 2020-03-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210122741-A1 PYRIDINE COMPOUND SUBSTITUTED WITH AZOLE CYP2C19, CYP4A11, CYP11B1 ALOX5 40/4885ALDH1A1 378/4885KDM4E 169/4885
US-11365192-B2 Pyridine compound substituted with azole CYP2C19, CYP4A11, CYP11B1 ALOX5 40/4885ALDH1A1 378/4885KDM4E 169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.